Cariprazine is an orally active D2/D3 dopamine receptor antagonist. Cariprazine is an antipsychotic drug candidate for the potential treatment of schizophrenia, bipolar mania and depression
References
PubChem Literature
From Data Sources
• Gruender, G. et al.: Curr. Opin. Invest. Drugs, 11, 823 (2010): Seneca, N. et al.: Psychopharmacology, 218, 579 (2011)
• Kiss, B. et al.: J. Pharmacol. Exp. Therap., 333, 328 (2011)